NHS London Branded Medicines - Tranche B - September 2023
Details
- Buyer
- NHS England
- Supplier(s)
35 suppliers
- AVENTIS PHARMA LIMITED
- Abbvie Ltd
- Accord UK Ltd
- Almirall
- Astra Zeneca UK Limited
- Bayer Public Limited Company
- Celltrion Healthcare United Kingdom Ltd
- CST Pharma Limited
- Eli Lilly and Company Ltd
- Galapagos Biotech UK Ltd
- GEDEON RICHTER (UK) LIMITED
- Gilead Sciences Ltd, 280 High Holborn
- GLAXOSMITHKLINE UK LIMITED
- Ipsen
- Janssen Cilag Ltd
- Kent Pharma Ltd
- Merck Serono Limited
- MERCK SHARP & DOHME (UK) LIMITED
- Mylan
- Neon Healthcare Ltd
- Novartis Pharmaceutical UK Ltd
- Novo Nordisk Ltd
- Organon Pharmaceuticals UK Ltd
- Orifarm UK
- Pfizer Liimted
- Ranbaxy (UK) Ltd
- Roche Products Ltd
- Sandoz
- Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
- Takeda UK Limited
- Teva UK Ltd
- Thornton and Ross
- Typharm Ltd
- UCB Pharma Ltd
- Zentiva Pharma UK Ltd
- Value
- £231,083,000
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 11 August 2023
- Source
- uk:contracts_finder
Tender description
NHS London Branded Medicines - Tranche B - September 2023 Offer reference number: CM/PHR/22/5677 CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5677/02 - NHS Framework for London Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
Timeline
- Completed: Award published11 August 2023Current notice
- Completed: Award date1 September 2023
- Completed: Contract expiry date31 August 2025
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
13 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
Generic Drugs - Oral Liquids
- Open tender
Injection Equipment Paraphernalia
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 510£244.6m
- 448£1.6bn
- 406£111.5m
- 400£699.7m
- 326£1.2bn
- 320£24.3bn
- 291£1.6bn
- 248£3.1bn
- 155£125.7m
- 150£1.0bn
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.